Skip to main content
Premium Trial:

Request an Annual Quote

Pat Brooks, Rebecca Galler, Keith Jones

Mission Bio has hired Pat Brooks as senior vice president of sales and sales operations, Rebecca Galler as senior vice president of marketing, and Keith Jones as senior vice president of product development.  

Brooks was previously vice president of global sales and development at Cellular Dynamics International. Prior to that, he held vice president positions at Ion Torrent, Pacific Biosciences, and Affymetrix. Brooks has a master of science and a bachelor of science degree from the University of Iowa.

Galler previously was previously involved in strategic marketing for Qventus and Castlight Health. In the past, she was head of corporate strategy at Sirna Therapeutics, director of private equity at Invesco Funds Group, and vice president of marketing at Preferred Global Health. She holds an MBA from Columbia University and a BA from Barnard College.

Jones used to be senior vice president of molecular assay research and development at Verinata Health, now part of Illumina. In the past, he was vice president of molecular genetics at Affymetrix. He holds a PhD in pharmacology from Stanford University School of Medicine and undergraduate degrees in chemistry and biological sciences from the University of California, Irvine.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.